Priliximab (CEN 000029), an anti-CD4 humanized monoclonal antibody, binds to CD4 receptors on T cells, leading to a significant and sustained decrease in circulating CD4+ T cells. This property renders it useful in the study of rheumatoid arthritis (RA)
CAS Number:
[147191-91-1]
* VAT and and shipping costs not included. Errors and price changes excepted